Chair of the Medicines Australia Board, VIC
Dr Anna Lavelle was appointed as Chair of the Medicines Australia Board in August 2018 and was recently reappointed as Chair for a three-year period. Prior to this, Dr Lavelle served as Deputy Chair and Independent Director of Medicines Australia from January 2017 to July 2018.
Dr Lavelle is an experienced Non-Executive Director serving for nearly 30 years on the boards of not for profit, government and for-profit entities. As Executive Director or Non-Executive Director, she has a long track record in healthcare delivery, technology development and negotiating government policy.
From 2005 to 2016, Dr Lavelle was the CEO of AusBiotech; the national industry association for the biotechnology, pharmaceutical and medical devices sectors. Dr Lavelle serves on several boards including, Chair Avatar Brokers, Non-Executive Director Hemideina Pty Ltd, Non-Executive Director Cyban Pty Ltd, Member Health Innovation Advisory Committee (National Health & Medical Research Council), Independent Director SoilCRC and Advisory Board member OUTBREAK initiative.
Dr Lavelle is an ATSE Fellow, has a PhD in Genetics and is an AICD Graduate.Back